Joshua Phillips

Joshua Phillips has a diverse work experience, holding various director roles in multiple companies. Joshua began their career as a Managing General Partner at CHV in 2007. Since then, they have worked as a Director at Pavilion Medical Innovations, LLC (from 2009), Sera Prognostics (from 2011), Saphena Medical, Inc. (from 2013), Cruzar Medsystems Inc (from 2013), Conformal Medical, Inc. (from 2018), Brixton Biosciences, Inc. (from 2019), Eyecool Therapeutics (from 2021), and currently at Epitel (from 2022). Joshua also served as a Director at SevenOaks Biosystems from 2014 to 2018.

Joshua Phillips attended Vanderbilt University from 1984 to 1988, where they earned a Bachelor of Engineering (BE) degree with a focus on Electrical Engineering and Mathematics. Joshua later pursued further education at Harvard Business School from 1996 to 1997, obtaining a Master of Business Administration (MBA) degree with a specialization in Business.